stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Free cash flow
QIAGEN N.V.'s free cash flow for fiscal 2025 was $447.2M, down 11.0% from $502.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $440.6M. Over the past ten years it has ranged from $56.0M (fiscal 2019) to $565.9M (fiscal 2022); the current reading is higher than 82% of that period. QIAGEN N.V. ranks 13th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $447.2M | (10.97%) |
| FY2024 | $502.3M | 69.33% |
| FY2023 | $296.7M | (47.58%) |
| FY2022 | $565.9M | 30.86% |
| FY2021 | $432.5M | 181.61% |
| FY2020 | $153.6M | 174.43% |
| FY2019 | $56.0M | (73.19%) |
| FY2018 | $208.7M | 28.52% |
| FY2017 | $162.4M | (34.44%) |
| FY2016 | $247.7M | 23.80% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $157.3M | 201.69% |
| Mar 2026 | $52.1M | (55.26%) |
| Dec 2025 | $116.6M | 1.73% |
| Sep 2025 | $114.6M | (5.00%) |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ICLR ICON PLC compare | $857.1M |
| MEDP Medpace Holdings, Inc. compare | $667.6M |
| RVTY Revvity Inc. compare | $602.5M |
| QGEN QIAGEN N.V. | $440.6M |
| CRL Charles River Laboratories International, Inc. compare | $399.6M |
| RDNT RadNet, Inc. compare | $74.4M |
| BLLN BillionToOne, Inc. compare | $33.9M |
| GH Guardant Health, Inc. compare | −$232.1M |
| GRAL GRAIL, Inc. compare | −$312.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement